Semaphorin 3A inactivation suppresses ischemia-reperfusion-induced inflammation and acute kidney injury

American Journal of Physiology - Renal Physiology

Volumn 307, Issue 2, 2014, Pages

  Ranganathan, Punithavathi ^a   Jayakumar, Calpurnia ^a   Mohamed, Riyaz ^a   Weintraub, Neal L ^a   Ramesh, Ganesan ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Acute kidney injury; Cisplatin; Semaphorin3A

Indexed keywords

CISPLATIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPILIN 1; SEMAPHORIN 3A; TOLL LIKE RECEPTOR 4;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EPITHELIUM CELL; GENE EXPRESSION; GENE INACTIVATION; HISTOPATHOLOGY; IN VITRO STUDY; INFLAMMATION; KIDNEY CELL; KIDNEY EPITHELIUM; KIDNEY ISCHEMIA; MACROPHAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REPERFUSION INJURY; URINARY EXCRETION;

ACUTE KIDNEY INJURY; CISPLATIN; SEMAPHORIN3A;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; CISPLATIN; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; INFLAMMATION MEDIATORS; KIDNEY; KIDNEY TUBULES; MACROPHAGES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; NEPHRITIS; NEUROPILIN-1; REPERFUSION INJURY; SEMAPHORIN-3A; TOLL-LIKE RECEPTOR 4;

EID: 84904368260     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00177.2014     Document Type: Article

References (36)

1. Bagri A, Marin O, Plump AS, Mak J, Pleasure SJ. Slit proteins prevent midline crossing and determine the dorsoventral position of major axonal pathways in the mammalian forebrain. Neuron 33: 233-248, 2002.
2. Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature 383: 525-528, 1996.
3. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204-R212, 2004.
4. Bielenberg DR, Klagsbrun M. Targeting endothelial and tumor cells with semaphorins. Cancer Metastasis Rev 26: 421-431, 2007.
5. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 66: 480-485, 2004.
6. Catalano A, Caprari P, Moretti S, Faronato M, Tamagnone L, Procopio A. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. Blood 107: 3321-3329, 2006.
7. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104: 343-348, 1998.
8. de Wit J, Verhaagen J. Role of semaphorins in the adult nervous system. Prog Neurobiol 71: 249-267, 2003.
9. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17: 1503-1520, 2006.
10. Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem 282: 26294-26305, 2007.
11. He Z, Tessier-Lavigne M. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90: 739-751, 1997.
12. Himmelfarb J, Joannidis M, Molitoris B, Schietz M, Okusa MD, Warnock D, Laghi F, Goldstein SL, Prielipp R, Parikh CR, Pannu N, Lobo SM, Shah S, D'Intini V, Kellum JA. Evaluation and initial management of acute kidney injury. Clin J Am Soc Nephrol 3: 962-967, 2008.
13. Hoste EA, Schurgers M. Epidemiology of acute kidney injury: how big is the problem? Crit Care Med 36: S146-S151, 2008.
14. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospitalacquired renal insufficiency: a prospective study. Am J Med 74: 243-248, 1983.
15. Jayakumar C, Ranganathan P, Devarajan P, Krawczeski CD, Looney S, Ramesh G. Semaphorin 3A is a new early diagnostic biomarker of experimental and pediatric acute kidney injury. PLos One 8: e58446, 2013.
16. Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron Exp Nephrol 109: e102-e107, 2008.
17. Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD. Neuropilin is a semaphorin III receptor. Cell 90: 753-762, 1997.
18. Kumanogoh A, Kikutani H. Immune semaphorins: a new area of semaphorin research. J Cell Sci 116: 3463-3470, 2003.
19. Li L, Huang L, Sung SS, Vergis AL, Rosin DL, Rose CE Jr, Lobo PI, Okusa MD. The chemokine receptors CCR2 and CX3CR1 mediate monocyte//macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 74: 1526-1537, 2008.
20. Li L, Okusa MD. Macrophages, dendritic cells, and kidney ischemiareperfusion injury. Semin Nephrol 30: 268-277, 2010.
21. Mikule K, Gatlin JC, de la Houssaye BA, Pfenninger KH. Growth cone collapse induced by semaphorin 3A requires 12/15-lipoxygenase. J Neurosci 22: 4932-4941, 2002.
22. Moretti S, Procopio A, Lazzarini R, Rippo MR, Testa R, Marra M, Tamagnone L, Catalano A. Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts. Blood 111: 2290-2299, 2008.
23. Ramesh G, Reeves WB. p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol 289: F166-F174, 2005.
24. Ratliff BB, Rabadi MM, Vasko R, Yasuda K, Goligorsky MS. Messengers without borders: mediators of systemic inflammatory response in AKI. J Am Soc Nephrol 24: 529-536, 2013.
25. Robert B, Zhao X, Abrahamson DR. Coexpression of neuropilin-1, Flk1, and VEGF(164) in developing and mature mouse kidney glomeruli. Am J Physiol Renal Physiol 279: F275-F282, 2000.
26. Roth L, Koncina E, Satkauskas S, Cremel G, Aunis D, Bagnard D. The many faces of semaphorins: from development to pathology. Cell Mol Life Sci 66: 649-666, 2009.
27. Shi H, Patschan D, Dietz GPH, Bähr M, Plotkin M, Goligorsky MS. Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury. Am J Physiol Renal Physiol 294: F229-F235, 2008.
28. Sun KLW, Correia JP, Kennedy TE. Netrins: versatile extracellular cues with diverse functions. Development 138: 2153-2169, 2011.
29. Tadagavadi RK, Wang W, Ramesh G. Netrin-1 regulates Th1/Th2/Th17 cytokine production and inflammation through UNC5B receptor and protects kidney against ischemia-reperfusion injury. J Immunol 185: 3750-3758, 2010.
30. Tufro A, Teichman J, Woda C, Villegas G. Semaphorin3a inhibits ureteric bud branching morphogenesis. Mech Dev 125: 558-568, 2008.
31. Vadasz Z, Ben Izhak O, Bejar J, Sabo E, Kessel A, Storch S, Toubi E. The involvement of immune semaphorins and neuropilin-1 in lupus nephritis. Lupus 20: 1466-1473, 2011.
32. Valouskova E, Smolkova K, Santorova J, Jezek P, Modriansky M. Redistribution of cell death-inducing DNA fragmentation factor-like effector-a (CIDEa) from mitochondria to nucleus is associated with apoptosis in HeLa cells. Gen Physiol Biophys 27: 92-100, 2008.
33. Villegas G, Tufro A. Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney. Mech Dev 119, Suppl 1: S149-S153, 2002.
34. Wen H, Lei Y, Eun SY, Ting Y. Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor-and sepsis-induced cytokine storm. J Exp Med 207: 2943-2957, 2010.
35. Williams G, Eickholt BJ, Maison P, Prinjha R, Walsh FS, Doherty P. A complementary peptide approach applied to the design of novel semaphorin/ neuropilin antagonists. J Neurochem 92: 1180-1190, 2005.
36. Zanoni I, Ostuni R, Granucci F. Generation of mouse bone marrowderived dendritic cells (BM-DCs). Protocol Exchange doi:10.1038/ nprot.2009.137.